An assessment of aetiology-based guidelines for the management of nausea and vomiting in patients with advanced cancer

Supportive Care in Cancer

Volumn 14, Issue 4, 2006, Pages 348-353

  Stephenson, Jeffrey ^a   Davies, Andrew ^b  

^a St Luke's Hospice   (United Kingdom)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Antiemetics; Nausea; Neoplasms; Palliative care; Vomiting

Indexed keywords

ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIEMETIC AGENT; ANTIFUNGAL AGENT; BENZODIAZEPINE DERIVATIVE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CYCLIZINE; CYTOTOXIC AGENT; DEXAMETHASONE; DIGOXIN; HALOPERIDOL; LEVOMEPROMAZINE; METOCLOPRAMIDE; OCTREOTIDE; OPIATE DERIVATIVE; PHENOTHIAZINE DERIVATIVE; SCOPOLAMINE BUTYL BROMIDE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ADVANCED CANCER; AGED; ARTICLE; FEMALE; HOSPITAL ADMISSION; HUMAN; INTESTINE OBSTRUCTION; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; STOMACH EMPTYING; SYMPTOMATOLOGY; TREATMENT OUTCOME; VOMITING;

ADULT; AGED; AGED, 80 AND OVER; ANTIEMETICS; FEMALE; GREAT BRITAIN; GUIDELINES; HUMANS; MALE; MIDDLE AGED; MORPHOLINES; NAUSEA; NEOPLASMS; PALLIATIVE CARE; PROSPECTIVE STUDIES; VOMITING;

EID: 33646423801     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-005-0897-1     Document Type: Article

References (12)

1. Bentley A, Boyd K (2001) Use of clinical pictures in the management of nausea and vomiting: a prospective audit. Palliat Med 15:247-253
2. Bruera E, Sweeney C (2002) Chronic nausea and vomiting. In: Berger AM, Portenoy RK, Weissman DE (eds) Principles and practice of palliative care and supportive oncology, 2nd edn. Lippincott Williams & Wilkins, Philadelphia, pp 222-232
3. Cherny N, Ripamonti C, Pereira J, Davis C, Fallon M, McQuay H, Mercadante S, Pasternak G, Ventafridda V, Expert Working Group of the European Association of Palliative Care Network (2001) Strategies to manage the adverse effects of oral morphine: an evidence-based report. J Clin Oncol 19:2542-2554
4. Dunlop GM (1989) A study of the relative frequency and importance of gastrointestinal symptoms, and weakness in patients with far advanced cancer. Palliat Med 4:37-43
5. Glare P, Pereira G, Kristjanson LJ, Stockler M, Tattersall M (2004) Systematic review of the efficacy of antiemetics in the treatment of nausea in patients with far-advanced cancer. Support Care Cancer 12:432-440
6. Jordhoy MS, Kaasa S, Fayers P, Ovreness T, Underland G, Ahlner-Elmqvist M (1999) Challenges in palliative care research; recruitment, attrition and compliance: experience from a randomized controlled trial. Palliat Med 13:299-310
7. Lichter I (1993) Results of antiemetic management in terminal illness. J Palliat Care 9:19-21
8. Loprinzi CL, Michalak JC, Schaid DJ, Mailliard JA, Athmann LM, Goldberg RM, Tschetter LK, Hatfield AK, Morton RF (1993) Phase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia. J Clin Oncol 11:762-767
9. Mannix KA (1998) Palliation of nausea and vomiting. In: Doyle D, Hanks GWC, MacDonald N (eds) Oxford textbook of palliative medicine, 2nd edn. Oxford University Press, Oxford, pp 489-499
10. Miller AD, Rowley HA, Roberts TP, Kucharczyk J (1996) Human cortical activity during vestibular and drug-induced nausea detected using M.S.I. In: Highstein SM, Cohen B, Buttner-Ennever JA (eds) New directions in vestibular research. New York Academy of Sciences, New York, pp 670-672
11. Twycross R, Back I (1998) Nausea and vomiting in advanced cancer. Eur J Palliat Care 5:39-45
12. Twycross RG, Lack SA (1986) Nausea and vomiting. In: control of alimentary symptoms in far advanced cancer. Churchill Livingstone, Edinburgh, pp 117-165